FDA OKs Medtronic's heart failure ICD (implantable cardioverter defibrillator) device
This article was originally published in Clinica
The US FDA has approved Medtronic's implantable device that combines cardiac resynchronisation therapy with a defibrillator to treat high-risk heart failure (HF) patients.
You may also be interested in...
The Trump administration does not believe its partnership with industry on therapeutics for COVID-19 should include conditions on pricing, US Health Secretary Alex Azar tells Congress.